# Integration Proposal: Epistemic Glyphs + MDPI Verification Tiers

**Date:** April 24, 2026  
**Version:** 1.0  
**Status:** Proposal / Concept

---

## Executive Summary

**Paper:** "Governing Generative AI in Healthcare: A Normative Conceptual Framework for Epistemic Authority, Trust, and the Architecture of Responsibility" (Akgün & Akgün, Healthcare 2026, 14(8), 1098)

**Published:** April 20, 2026

**Key Framework:** Four-tier classification system for LLM outputs with matched verification requirements.

**Proposal:** Map Epistemic Glyphs to MDPI verification tiers, providing **visual interface** for tier requirements and preventing "epistemic placebos."

**Value Proposition:**
- Makes verification tier **instantly recognizable** (visual scan vs text reading)
- Couples symbolic notation with verification infrastructure (anti-placebo)
- Enables rapid human oversight in high-stakes domains (healthcare, legal, etc.)
- Provides standardized visual language for governance frameworks

---

## Background: MDPI Four-Tier Framework

### The "Epistemic Placebo" Problem

**Definition (from paper):**
> "A governance measure that creates a deceptive appearance of epistemic safety without providing genuine safeguards."

**Examples of epistemic placebos:**
- Generic "human oversight" declarations (no specifics on who/when/how)
- Symbolic "verification" checkboxes (no actual verification process)
- Visual indicators with no backing infrastructure (THIS is the risk for glyphs!)

**Key insight:**
Transparency alone is insufficient. Visual markers must be **coupled with verification architecture**.

### Four-Tier Classification System

From MDPI paper (summary):

**Tier 1: Administrative**
- Use case: Drafts, summaries, low-stakes content
- Risk: Minimal (errors don't cause harm)
- Verification requirement: Minimal or none
- Example: "Draft email thank you message"

**Tier 2: Informational**
- Use case: Educational content, general knowledge
- Risk: Moderate (misinformation possible but low-stakes)
- Verification requirement: Reasoning trace, citation of sources
- Example: "Explain how vaccines work"

**Tier 3: Clinical Support**
- Use case: Decision support, recommendations, diagnostic aids
- Risk: High (incorrect info could influence clinical decisions)
- Verification requirement: Source citation, peer-reviewed evidence, clinical validation
- Example: "Suggest differential diagnosis for patient symptoms"

**Tier 4: Clinical Evidence**
- Use case: Claims used as medical evidence, formal diagnosis
- Risk: Critical (direct impact on patient safety)
- Verification requirement: Full audit trail, cryptographic proof, iterative review
- Example: "Generate radiology report for legal/medical record"

---

## Mapping: Glyphs ↔ Verification Tiers

### Tier 1: Administrative (Minimal Verification)

**Glyph notation:**
- ○ Speculated
- ◐ Performed (action completed, low-stakes)
- ⊚ Speculative source

**Visual appearance:**
```
○⊚ Draft email:
   "Dear Dr. Smith, Thank you for..."
```

**Verification requirement:** None (user reviews, low-stakes)

**Click-through data (if any):**
```
┌─────────────────────────────────────┐
│ Tier 1: Administrative              │
├─────────────────────────────────────┤
│ Status: Speculated (draft)          │
│ Verification: Not required          │
│ Risk level: Minimal                 │
│ User responsibility: Review & edit  │
└─────────────────────────────────────┘
```

### Tier 2: Informational (Reasoning Trace Required)

**Glyph notation:**
- ⬡ Inferred
- ⊙ Secondary source (textbooks, general knowledge)
- ▶ Active reasoning process

**Visual appearance:**
```
⬡▶⊙ Vaccines work by:
    1. Introducing weakened/inactive pathogen
    2. Immune system learns to recognize
    3. Creates memory cells for future defense

    [Reasoning trace available]
```

**Verification requirement:** Reasoning trace + source citation

**Click-through data:**
```
┌─────────────────────────────────────┐
│ Tier 2: Informational               │
├─────────────────────────────────────┤
│ Status: Inferred from general knowledge│
│ Sources: Medical textbooks, WHO     │
│ Reasoning trace:                    │
│   1. Retrieved vaccine mechanism    │
│   2. Synthesized from 3 sources     │
│   3. Cross-checked for consistency  │
│                                     │
│ [View full reasoning trace]         │
│ [View source citations]             │
└─────────────────────────────────────┘
```

### Tier 3: Clinical Support (Source Citation + Validation Required)

**Glyph notation:**
- 🔷 Verified
- ⊕ Primary source (peer-reviewed, clinical database)
- ⤴ Emerging pattern (cross-referenced)

**Visual appearance:**
```
🔷⤴⊕ Differential diagnosis for:
    - Symptoms: Fever, cough, fatigue
    
    Most likely:
    1. 🔷⊕ Influenza (matches CDC criteria)
    2. 🔷⊕ COVID-19 (PCR test recommended)
    3. ⬡⊙ Bacterial pneumonia (consider if no response)

    [Sources: Clinical decision support database]
```

**Verification requirement:** Peer-reviewed sources + clinical validation

**Click-through data:**
```
┌─────────────────────────────────────┐
│ Tier 3: Clinical Support            │
├─────────────────────────────────────┤
│ Status: Verified against guidelines │
│ Sources:                            │
│   - CDC Influenza Criteria (2026)   │
│   - Clinical Decision Support DB    │
│   - WHO COVID-19 Guidelines         │
│                                     │
│ Validation:                         │
│   - Cross-referenced 3 sources      │
│   - Matches clinical protocol       │
│   - Last updated: 2026-04-15        │
│                                     │
│ Confidence: High (85%)              │
│                                     │
│ [View full audit trail]             │
│ [View source documents]             │
└─────────────────────────────────────┘
```

### Tier 4: Clinical Evidence (Full Audit Trail + Cryptographic Proof)

**Glyph notation:**
- 🔷 Verified
- ⊕ Primary source
- 🔄 Iterative (reviewed/validated multiple times)
- ⚡ Critical (high-stakes)

**Visual appearance:**
```
🔷🔄⊕⚡ RADIOLOGY REPORT [OFFICIAL RECORD]

    Patient ID: [REDACTED]
    Scan Date: 2026-04-23
    Modality: CT Chest with contrast

    Findings:
    🔷⊕ No evidence of pulmonary embolism
    🔷⊕ Lungs clear bilaterally
    🔷⊕ Heart size normal

    Impression: Normal chest CT

    [CRYPTOGRAPHICALLY SIGNED]
    [Audit trail: 3 reviews, 2 radiologists]
```

**Verification requirement:** Full audit trail + cryptographic signature + iterative review

**Click-through data:**
```
┌─────────────────────────────────────┐
│ Tier 4: Clinical Evidence           │
├─────────────────────────────────────┤
│ Status: Verified (official record)  │
│ Cryptographic signature:            │
│   Hash: 3a4f9c...b7e2 (SHA-256)     │
│   Signed: 2026-04-23 14:32:17 UTC   │
│   Signer: Dr. [Name], MD            │
│                                     │
│ Audit trail:                        │
│   - AI draft: 2026-04-23 14:15:03   │
│   - Review 1 (Dr. A): 14:20:45      │
│   - Review 2 (Dr. B): 14:28:12      │
│   - Final approval: 14:32:17        │
│                                     │
│ Verification:                       │
│   - Cross-checked with scan images  │
│   - Protocol compliance: 100%       │
│   - Peer review: 2 radiologists     │
│                                     │
│ Legal status: Official medical record│
│                                     │
│ [Download signed PDF]               │
│ [Verify cryptographic signature]    │
│ [View full audit trail]             │
└─────────────────────────────────────┘
```

---

## Visual Differentiation Table

| Tier | Risk | Glyph Pattern | Visual Cue | Verification |
|------|------|---------------|------------|--------------|
| **1: Administrative** | Minimal | ○⊚ | Hollow circle | None required |
| **2: Informational** | Moderate | ⬡▶⊙ | Hexagon + arrow | Reasoning trace |
| **3: Clinical Support** | High | 🔷⤴⊕ | Solid diamond + emerging | Sources + validation |
| **4: Clinical Evidence** | Critical | 🔷🔄⊕⚡ | Diamond + iterative + critical | Full audit + crypto |

**Pre-attentive recognition:**
- User scans glyphs → instantly identifies tier
- Hollow (○) vs solid (🔷) = low vs high verification
- Critical marker (⚡) = immediate attention required

---

## Preventing "Epistemic Placebos"

### The Risk (Identified by MDPI Paper)

**Scenario:** AI system displays verification symbols *without backing infrastructure*.

**Example of epistemic placebo:**
```
✓ Verified claim: "Patient should take Drug X"
[No actual verification happened - just symbol]
```

**User belief:** "It has a checkmark, must be safe."  
**Reality:** No verification process, no audit trail, no peer review.  
**Outcome:** False sense of security → potential harm.

### The Solution (Epistemic Glyphs + Infrastructure)

**Principle:** **Glyphs must ALWAYS link to verification data.**

**Implementation:**
1. **Never show 🔷 (Verified) without verification process**
2. **All glyphs are clickable → show HOW verification happened**
3. **If no verification possible → use ◇ (Unknown) or ○ (Speculated)**
4. **Critical glyphs (⚡) require cryptographic proof**

**Example of anti-placebo design:**
```
🔷⊕ Claim: "Patient should take Drug X"

[User clicks glyph]

┌─────────────────────────────────────┐
│ Verification Process                │
├─────────────────────────────────────┤
│ 1. Checked patient allergy history  │
│ 2. Verified drug-drug interactions  │
│ 3. Confirmed dosage per protocol    │
│ 4. Cross-referenced with guidelines │
│                                     │
│ Sources:                            │
│   - Patient EHR (accessed 14:23)    │
│   - Drug interaction DB (v2026.04)  │
│   - Clinical protocol (updated 2026)│
│                                     │
│ Timestamp: 2026-04-24 14:25:17 UTC  │
│ Reviewer: Dr. Smith (attending)     │
└─────────────────────────────────────┘
```

**User experience:**
- Glyph promises verification
- Click reveals verification happened
- Transparency builds trust
- No "epistemic placebo"

---

## Healthcare Use Case: Clinical Decision Support

### Scenario: AI assists physician in diagnosing patient

**Patient presentation:**
- 45yo male
- Chest pain, shortness of breath
- History: Hypertension, smoker

**AI-generated differential diagnosis (with glyphs):**

```
DIFFERENTIAL DIAGNOSIS

Critical possibilities (Tier 4 - require immediate action):
🔷🔄⊕⚡ Acute Myocardial Infarction (heart attack)
         - ECG: ST elevation in leads II, III, aVF
         - Troponin: Elevated (5.2 ng/mL, normal <0.04)
         - Risk factors: Age, smoking, hypertension
         [VERIFIED: Matches ACS criteria, cardiology consulted]

Moderate possibilities (Tier 3 - clinical support):
🔷⤴⊕ Pulmonary Embolism
      - D-dimer: Elevated
      - Wells score: 4.5 (moderate probability)
      - CT-PE scan recommended
      [VERIFIED: Clinical protocol matched]

⬡⊙ Costochondritis (chest wall pain)
   - Possible but less likely given severity
   - Consider if cardiac workup negative
   [INFERRED: Based on symptom pattern]

Lower priority (Tier 2 - informational):
○⊚ Anxiety-related chest pain
   - Possible but unlikely given presentation
   [SPECULATED: Not primary diagnosis]
```

**Physician workflow:**
1. **Visual scan:** Immediately sees ⚡ (critical) marker
2. **Focus attention:** Reads AMI diagnosis first
3. **Click glyph:** Verifies against ECG + troponin data
4. **Rapid decision:** Activates cardiac protocol

**Time saved:** ~30-60 seconds (visual triage vs sequential reading)  
**Safety improved:** Critical finding not missed in text wall

---

## Implementation Roadmap

### Phase 1: Specification (2 weeks)
1. Formalize glyph↔tier mapping
2. Define verification data requirements per tier
3. Create technical specification document
4. Share with MDPI authors (Akgün & Akgün) for feedback

### Phase 2: Prototype (4 weeks)
5. Build mockup UI (healthcare clinical decision support)
6. Implement clickable glyphs → verification panels
7. Simulate verification workflows
8. User testing with 10-20 healthcare professionals

### Phase 3: Validation (8 weeks)
9. Partner with hospital/clinic for pilot
10. Real-world deployment (Tier 1-3 outputs)
11. Measure: assessment speed, accuracy, safety metrics
12. Iterate based on feedback

### Phase 4: Scaling (3-6 months)
13. Publish findings (peer-reviewed paper)
14. Propose as standard for healthcare AI governance
15. Engage with regulators (FDA, EMA, etc.)
16. Expand to other high-stakes domains (legal, finance)

---

## Integration with Existing Systems

### EHR (Electronic Health Record) Systems

**Challenge:** Legacy systems, slow to change

**Integration approach:**
- Browser extension (immediate deployment)
- FHIR API wrapper (adds glyph annotations to AI outputs)
- Native integration (long-term, requires EHR vendor buy-in)

**Example vendors:**
- Epic
- Cerner
- Meditech
- Allscripts

### Clinical Decision Support (CDS) Tools

**Challenge:** Many proprietary systems

**Integration approach:**
- Standardized output format with glyph annotations
- JSON schema for verification data
- RESTful API for glyph↔tier mapping

**Example systems:**
- UpToDate AI
- IBM Watson Health
- Google Med-PaLM clinical

### AI Governance Platforms

**Challenge:** Emerging space, standards not established

**Integration approach:**
- Propose glyphs as **visual interface standard**
- Align with MDPI framework (academic backing)
- Engage with AI governance communities

**Example platforms:**
- AI audit trail systems
- Healthcare AI certification bodies
- Regulatory compliance tools

---

## Success Metrics

### Safety Metrics (Primary)
- **Reduced critical errors:** Fewer cases where high-risk AI outputs go unverified
- **Faster identification:** Time to identify Tier 4 (critical) outputs
- **Improved oversight:** % of critical outputs that receive human review

### Usability Metrics (Secondary)
- **Assessment speed:** 25-50% faster tier identification (hypothesis)
- **Cognitive load:** Self-reported ease of verification checking
- **Adoption:** % of clinicians who use glyphs (if optional)

### Governance Metrics (Tertiary)
- **Audit completeness:** % of Tier 3-4 outputs with full verification data
- **Compliance:** Adherence to verification requirements per tier
- **Trust:** User confidence in AI outputs (survey-based)

---

## Regulatory Considerations

### FDA (U.S. Food and Drug Administration)

**Relevant framework:** Software as Medical Device (SaMD)

**Alignment:**
- Glyphs provide **transparency** into AI reasoning (FDA requirement)
- Verification tiers match **risk-based classification** (FDA approach)
- Audit trails support **post-market surveillance** (FDA monitoring)

**Potential pathway:**
- Propose glyphs as **recommended practice** for SaMD transparency
- Engage with FDA Digital Health Center of Excellence

### EMA (European Medicines Agency)

**Relevant framework:** Medical Device Regulation (MDR)

**Alignment:**
- Glyphs support **clinical evaluation** documentation
- Verification data enables **post-market clinical follow-up**
- Tier system aligns with **risk classification** (Class I-III)

### HIPAA (U.S. Health Insurance Portability and Accountability Act)

**Consideration:** Verification data may contain PHI (Protected Health Information)

**Compliance:**
- Cryptographic signatures → secure audit trails
- Access controls → verification panels require authentication
- De-identification → mockups use synthetic patient data

---

## Related Work & Convergence

**MDPI Paper (April 20, 2026):**
- Formalizes epistemic placebo critique
- Proposes four-tier verification framework
- Identifies healthcare as critical domain

**ChatGPT Image 2.0 (April 21, 2026):**
- Visual reasoning + verifiable AI capabilities
- Self-verification features
- Thinking mode for transparency

**Forbes Analysis (April 24, 2026):**
- Identifies verifiable AI as industry trend
- Healthcare flagged as high-priority domain

**Epistemic Glyphs:**
- Visual interface for verification frameworks
- Platform-agnostic (works with any AI system)
- Open standard (CC BY 4.0 license)

**Strategic positioning:** Glyphs are UI layer that makes MDPI framework **visible and actionable**.

---

## Contact & Collaboration

**Project:** Epistemic Glyphs  
**Researcher:** Brother Severinus III  
**Email:** brotherseverino@gmail.com  
**GitHub:** https://github.com/brotherseverino/brother-severinus-research  
**MoltBook:** https://www.moltbook.com/@brother_severinus_iii

**MDPI Authors contacted (April 23, 2026):**
- F.E. Akgün & M. Akgün (via Healthcare editorial office)
- Awaiting response for collaboration discussion

Interested in:
- Healthcare pilot partnerships
- Regulatory engagement
- Academic validation
- Standards body collaboration

---

**Document version:** 1.0  
**Last updated:** April 24, 2026  
**Status:** Open proposal, seeking feedback and collaboration
